Clinical trial Recruiting at 2 sites Phase 1 Interventional Ages 3 and up

AdiaVita and glutathione for autism in kids and teens

Official title: Greater Atlanta Integrative Pediatrics Autism Spectrum Disorder Research Study

Run by Greater Atlanta Integrative Pediatrics · NCT07622316 · Data updated 2026-11-12

This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.

More Autism trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages3 Years and up
SexAll
Enrollment100 (estimated)
SponsorGreater Atlanta Integrative Pediatrics
Academic / other
Locations2 sites (Roswell, Georgia and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJune 3, 2026
Trial IDNCT07622316 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adults aged 3 years and older with a confirmed ASD diagnosis who can attend study visits and have parental/guardian consent.

Probably not a fit

Participants with uncontrolled medical conditions, immune compromise, ongoing interventional trial participation, or intolerance to study products may not benefit and could be excluded based on safety criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a Phase 1 randomized, participant-blinded crossover trial enrolling about 100 individuals aged 3 and older with autism. Participants are assigned to three monthly infusions of AdiaVita plus glutathione or placebo saline with glutathione, followed by a potential crossover to the experimental treatment for eligible controls. The primary outcome is change in Autism Treatment Evaluation Checklist (ATEC) scores, with safety monitored for 12 months. The study is investigational and not FDA-approved for autism, and procedures include bloodwork and regular visits, conducted largely in the Atlanta area. Participants and families should note the cost of the initial treatment schedule and the importance of adherence to study visits and safety follow-up.

Why it matters

Potential benefit: If successful, the treatment could offer a new approach that may reduce ASD-related symptoms and improve quality of life for some participants.

How similar studies have gone: Prior cord blood studies in pediatric ASD have suggested acceptable safety, but this approach remains investigational with limited efficacy data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 3 years and up
* Confirmed ASD diagnosis (DSM-5 criteria, supported by ADOS-2 or its equivalent)
* Parent/guardian willingness to consider experimental treatments and comply with study requirements
* Ability to obtain required bloodwork
* Ability to attend all scheduled visits

Exclusion Criteria:

* Severe allergies to study products
* Significant uncontrolled medical conditions
* Immunocompromised
* Malignancy history
* Unstable medication regimen or inconsistent medication adherence (e.g., frequent medication changes or missed doses) within 30 days prior to Baseline, at Investigator discretion
* Pregnancy or breastfeeding (if applicable)
* Participation in another interventional trial within 30 days

Where it's running

  • Greater Atlanta Integrative Pediatrics
    Roswell, Georgia, United States
    Recruiting
  • Greater Atlanta Integrative Pediatrics
    Roswell, Georgia, United States
    Recruiting

Study contacts

  • Principal investigator: Maia Gaither, MD — Greater Atlanta Integrative Pediatrics
  • Study coordinator: Maia Gaither, MD
  • Email: intakes@gaipeds.com
  • Phone: 4047513693

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.